MGC Pharma creates premium phytocannabinoid-based pharmaceutical products from our GMP certified facility in Europe that can be used to treat patients suffering from a variety of symptomatic conditions.

Using a unique labeling system across the range, MGC Pharma has made it simple to understand exactly what Genetic Materials are being utilized in each product. Within the range, each pharmaceutical solution offers a unique combination of cannabinoids in order to address different medical needs. You can learn about the benefits of each of the products below.

• Where we are
• Research
• Doctors
• Patients

Visit https://mgcpharma.com.au/

Locations

• AUSTRALIA
  • Pharma Corporate & Financial Headquarters
• SLOVENIA
  • Pharma European Operational Headquarters
• MALTA
• CZECH REPUBLIC
  • Botanical Research and Development Project
• UK
  • European Corporate Headquarters
• ISRAEL
  • Pharma Scientific Board